Distinguished Scholar Awards
The American College of Chest Physicians and The CHEST Foundation Award Application for the
GlaxoSmithKline Distinguished Scholar in Thrombosis
Applications for awards are now closed. DEADLINE: APRIL 30, 2008
Awards Background
Today, the idea of an endowed chair to provide the university or medical center with the resources necessary to have a subject or research area continued in perpetuity is an established concept and necessary funding mechanism to facilitate innovation. An endowed chair honors both its donors and its recipients, as it manifests to the community a commitment to a specific academic and/or research area.
The American College of Chest Physicians (ACCP) and The CHEST Foundation, its philanthropic arm, have adopted this tradition with the creation of an endowed scholars program. The goal is to provide an interval of financial support for clinical education projects that will improve patient care. In its role as the philanthropic arm of the ACCP, The CHEST Foundation supports prevention and education programs in cardiopulmonary health and broader medical issues of interest to ACCP members, their patients, and the public.
The Distinguished Scholar will represent a specialty encompassed by College membership, whose work will impact the College's global membership, extend its impact in clinical practice, and improve patient care by addressing clinical issues and pressing public health and policy problems. The concept is to leverage collaboration between the Distinguished Scholar and the College’s leadership and the Pulmonary Vascular Disease NetWork in a manner that will make a difference in the treatment and outcomes of patients with thromboembolism requiring care.
The GlaxoSmithKline Distinguished Scholar in Thrombosis will have a 3-year opportunity to examine issues that relate to patients with thromboembolism. The award is intended to permit the investigation of issues that are not easily supported by traditional funding, such as the development of public policy, patient education models, or economic analysis of treatment or care delivery in this patient group.
The ACCP and The CHEST Foundation are pleased and honored to announce the Second GlaxoSmithKline Distinguished Scholar in Thrombosis award. As a leader in its field, GlaxoSmithKline’s discoveries have contributed to improving the health and lives of many generations through its commitment to innovation and quality health care. By endowing a second Distinguished Scholar, GlaxoSmithKline is reflecting the importance of promoting new knowledge about thromboembolism that will translate into improvement in clinical practice and saving lives.
Award Selection Process
The CHEST Foundation Awards Committee of the College will select the Second Distinguished Scholar in Thrombosis for a term of 3 years. The primary role of the GlaxoSmtihKline Distinguished Scholar in Thrombosis will be to:
- Identify one or more projects that will make an outstanding contribution to the understanding and treatment of thromboembolism.
- Assist in the College's development of these projects to disseminate new knowledge about thromboembolism and foster the creation of best practices in patient care.
- Represent the College as the distinguished expert in the specialty area.
To assist in the development of outstanding projects, the Distinguished Scholar will receive a stipend of $50,000 annually over the 3-year term of the program. This stipend is not meant to fund a full time equivalent (FTE) position; it is meant to fund up to a 30% FTE. A fourth year stipend of $10,000 will be awarded to the individual who will serve in a mentorship role to the third Distinguished Scholar position during his/her inaugural year of service. This transition year mechanism will result in a smooth transfer of leadership, particularly because many projects will have a duration beyond the Distinguished Scholar’s term, while creating a vehicle to create a Distinguished Scholar Advisory Council.
Applicant Qualifications
To be considered as a candidate for the GlaxoSmithKline Distinguished Scholar in Thrombosis, an individual must:
- Be an FCCP and hold the degree of: MD; DO; MB, ChB; MB, BCh; MBBS; DNSc; Pharm D; PhD; or EdD.
- Be a recognized clinician and/or scientist with a specialty in thromboembolism as evidenced by publications, presentations, and/or peers
The Second Distinguished Scholar in Thrombosis will be announced at the Convocation Ceremony of the CHEST 2008 meeting in Philadelphia, Pennsylvania, where the recipient will communicate the focus of his/her project to ACCP's membership and strategic partners. At each successive annual meeting, the selected scholar will present a progress report to the ACCP and The CHEST Foundation leadership in order to assess progress and determine how to advance the development of identified programs and/or projects.
Primary Responsibilities
The successful candidate for the GlaxoSmithKline Distinguished Scholar in Thrombosis can anticipate the following responsibilities:
- Description of one or more projects in the area represented by the scholar that will make an outstanding contribution to the understanding and treatment of thromboembolism and foster the creation of best practices in patient care.
- Recruitment of ACCP members to participate in project programs utilizing ACCP and the Pulmonary Vascular Disease NetWork.
- Assistance in the development of implementation plans and project budgets working with College staff.
- Assistance of the ACCP Senior Vice President in securing funding for successful attainment of project goals.
- Assistance of the ACCP Marketing Department to publicize the project.
- Representation as the College’s distinguished expert in the specialty area.
- Dissemination of new knowledge about the understanding and treatment of thromboembolism.
Goals of The Distinguished Scholar in Thrombosis Projects
Among the goals of projects completed under the auspices of the GlaxoSmithKline Distinguished Scholar in Thrombosis endowment are to:
- Establish an identity for the diagnosis and management of thromboembolism.
- Promote alternatives for the treatment of thromboembolism.
- Educate patients about options for diagnosis and management.
- Educate and disseminate new knowledge about diagnosis and treatment.
- Address family, legislative, and regulatory issues, and define new funding mechanisms leading to innovations and improvement in the treatment of thromboembolism.
Project Requirements and Evaluation
The following will be required:
- A quarterly written report that will discuss progress toward attaining project goals, key outcomes to date, any barriers in completing the project on time, and dissemination strategies
- An oral presentation at the annual CHEST meeting
- Participation on quarterly conference calls with members of the Distinguished Scholar in Thrombosis Review Committee
Accompanying Materials
Please include the following materials with your completed application:
- Curriculum vitae
- Other supporting materials, such as any papers, reports, awards, or other materials that document your interest and ability to participate in the Distinguished Scholar program.
- A letter from the appropriate individual at your institution stating that you have the ability (time, budgetary, and intellectual property releases) to serve as the Distinguished Scholar for the 3-year tenure and the 1-year Advisory Committee term. Note: If selected as the Distinguished Scholar, a contract must be signed between The CHEST Foundation and the institution where you are employed.
Questions/Need for Further Information
Please direct any questions or inquiries about the application process to Sue Ciezadlo, Senior Project Coordinator of The CHEST Foundation, at (847) 498-8363 or sciezadlo@chestnet.org.
Sue
Ciezadlo
Senior Project Coordinator
The
CHEST Foundation
3300
Dundee Road
Northbrook,
IL 60062-2348
Tel: (847) 498-8363
Fax: (847) 498-5460
E-mail: sciezadlo@chestnet.org